Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Mitral Valve Insufficiency: early-phase trial registry

4 of 12 indexed Mitral Valve Insufficiency trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 4 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Mitral Valve Insufficiency: 12 US clinical trials tracked, 4 recruiting.

Mitral Valve Insufficiency is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Edwards Lifesciences, running 4 of these trials.

Enrollment posture brief

Registry condition mitral-valve-insufficiency

OPEN 4 | RECR 33% | LATE 0 | EARLY 1 | RANK #1429 | SPON 4

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Mitral Valve Insufficien (th…33%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Mitral Valve Insufficiency

Mitral Valve Insufficiency lists 4 open slots (33% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mitral Valve Insufficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mitral Valve Insufficiency is recruiting below its size-band peers.

    4 of 12 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Mitral Valve Insufficiency research.

    Edwards Lifesciences accounts for 4 of 12 trials (33.3%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Mitral Valve Insufficiency enrolment sits around 300 participants.

    Median target enrolment is 300 among the 12 trials that report a genuine target (sentinel values excluded). 2 of those (16.7%) plan for fewer than 100 participants.

  4. Mitral Valve Insufficiency research is mostly interventional.

    9 interventional and 3 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Open and recent trials

12 total, page 1 of 1

RECRUITING NA 900 participants

The ENCIRCLE Trial

Edwards Lifesciences

NCT04153292

RECRUITING NA 585 participants

Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

NeoChord

NCT02803957

RECRUITING NA 300 participants

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Cardiac Dimensions

NCT03142152

RECRUITING NA 30 participants

The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study

Half Moon Medical

NCT04343313

ACTIVE NOT RECRUITING NA 777 participants

ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

Edwards Lifesciences

NCT01757665

ACTIVE NOT RECRUITING 504 participants

Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve

Edwards Lifesciences

NCT05526560

ACTIVE NOT RECRUITING 368 participants

Long Term Follow Up for CTSN Mitral Valve Repair Studies

Icahn School of Medicine at Mount Sinai

NCT03066050

ACTIVE NOT RECRUITING NA 128 participants

Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System

Medtronic Cardiovascular

NCT02322840

ACTIVE NOT RECRUITING NA 103 participants

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Abbott Medical Devices

NCT03433274

ACTIVE NOT RECRUITING NA 53 participants

PARTNER 3 Trial - Mitral Valve in Valve

Edwards Lifesciences

NCT03193801

COMPLETED Phase 2 300 participants

Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

Avant Immunotherapeutics

NCT00082121

COMPLETED 200 participants

Investigation of Heart Function in Patients With Heart Valve Defects

National Heart, Lung, and Blood Institute (NHLBI)

NCT00001314

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Mitral Valve Insufficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

TP10 Drug
1 trials
Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System Device
1 trials
Twelve TMVR Implant Device
1 trials
Edwards SAPIEN 3 transcatheter valve, Model 9600TFX Device
1 trials
MitraClip System Device
1 trials
Tendyne Mitral Valve System Device
1 trials
MITRIS RESILIA Mitral Valve, Model 11400M Device
1 trials
CABG Other
1 trials

US sites by state

Facility locations filed on Mitral Valve Insufficiency trials. A trial with sites in several states counts in each.

Georgia 9 trials
California 9 trials
New York 7 trials
Florida 7 trials
Texas 5 trials
Pennsylvania 5 trials
Ohio 5 trials
Michigan 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mitral Valve Insufficiency page

12 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Mitral Valve Insufficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Edwards Lifesciences sponsors the most Mitral Valve Insufficiency trials on record, review their full trial history before evaluating a specific study. See Edwards Lifesciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mitral Valve Insufficiency condition card totals 12 registered trials; most-linked intervention TP10; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.